Patent abuse delays market entry for lower-cost generic medicines and keeps drug prices out of reach for Americans. Policymakers must take action to stop patent abuse.
Quick Links:
Generic and biosimilar medicines created $467 billion in savings in 2024—and $3.4 trillion in savings the last ten years.
Join us at GRx+Biosims 2026 on November 2–4, for the leading regulatory, science and policy event in the U.S.
Desi’s journey from painful swelling to playing soccer again shows the power of accessible medicines.
Learn how a biosimilar medication helped Eileen stay focused on auditions, not Crohn’s disease.
Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.
